We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$194M
AUM Growth
-$27.5M
Cap. Flow
-$34M
Cap. Flow %
-17.5%
Top 10 Hldgs %
72.83%
Holding
33
New
2
Increased
2
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
BLCO icon
Bausch + Lomb
BLCO
+$7.6M
2
OSCR icon
Oscar Health
OSCR
+$1.76M
3
MLCO icon
Melco Resorts & Entertainment
MLCO
+$896K
4
HLVX
HilleVax
HLVX
+$438K

Top Sells

Rank Stock Value
1
EDR
Endeavor Group Holdings, Inc.
EDR
+$11.4M
2
THC icon
Tenet Healthcare
THC
+$9.2M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$7.99M
4
CYTK icon
Cytokinetics
CYTK
+$4.85M
5
ATRC icon
AtriCure
ATRC
+$3.04M

Sector Composition

Rank Sector Weight
1 Healthcare 59.47%
2 Technology 17.58%
3 Consumer Discretionary 11.98%
4 Financials 9.39%
5 Communication Services 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.02T
$22.4M 11.51%
24,712
-3,364
-12% -$2.69M
UBER icon
2
Uber
UBER
$142B
$21.9M 11.27%
301,457
– –
VRTX icon
3
Vertex Pharmaceuticals
VRTX
$120B
$19.2M 9.9%
41,050
– –
MS icon
4
Morgan Stanley
MS
$334B
$18.2M 9.39%
187,714
– –
TEVA icon
5
Teva Pharmaceuticals
TEVA
$40.6B
$15.9M 8.2%
981,000
-519,000
-35% -$7.99M
PFE icon
6
Pfizer
PFE
$142B
$9.81M 5.05%
350,500
– –
TSM icon
7
TSMC
TSM
$2.11T
$9.01M 4.64%
51,826
– –
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$27.3B
$9M 4.63%
37,022
-15,900
-30% -$2.51M
BBWI icon
9
Bath & Body Works
BBWI
$4.03B
$8.67M 4.46%
221,902
-36,500
-14% -$1.68M
BLCO icon
10
Bausch + Lomb
BLCO
$5.9B
$7.35M 3.78%
+506,343
New +$7.6M
MLCO icon
11
Melco Resorts & Entertainment
MLCO
$2.25B
$7.34M 3.78%
983,694
+118,600
+14% +$896K
CZR icon
12
Caesars Entertainment
CZR
$6.05B
$5.87M 3.02%
147,625
– –
XENE icon
13
Xenon Pharmaceuticals
XENE
$6.09B
$5.72M 2.95%
146,800
– –
GERN icon
14
Geron
GERN
$828M
$5.67M 2.92%
1,338,084
– –
SWTX
15
DELISTED
SpringWorks Therapeutics
SWTX
$5.44M 2.8%
144,526
– –
DXCM icon
16
DexCom
DXCM
$31.9B
$3.28M 1.69%
28,900
– –
CPRX
17
DELISTED
Catalyst Pharmaceutical
CPRX
$2.86M 1.47%
184,527
– –
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$4.28T
$2.53M 1.3%
13,900
– –
QTRX icon
19
Quanterix
QTRX
$160M
$2.05M 1.05%
154,900
– –
HLVX
20
DELISTED
HilleVax
HLVX
$2.03M 1.04%
140,100
+31,900
+29% +$438K
MSFT icon
21
Microsoft
MSFT
$3.4T
$1.89M 0.97%
4,230
– –
TERN
22
DELISTED
Terns Pharmaceuticals
TERN
$1.68M 0.86%
246,800
– –
QURE icon
23
uniQure
QURE
$3.04B
$1.62M 0.84%
362,349
– –
OSCR icon
24
Oscar Health
OSCR
$9.39B
$1.51M 0.78%
+95,700
New +$1.76M
AMZN icon
25
Amazon
AMZN
$2.87T
$1.4M 0.72%
7,264
– –
1
2

Similar funds

SHFC
Safe Harbor Family Capital Chapel Hill, North Carolina $128M AUM
IUC
Ivory Union Consulting Road Town $128M AUM
PC
Pelham Capital London, United Kingdom $128M AUM 34.73% 1-Year Est. Return
SIM
Summitas Investment Management Mckinney, Texas $128M AUM
PIA
Prakash Investment Advisors Andover, Massachusetts $128M AUM 44.06% 1-Year Est. Return
S
Storgate Dallas, Texas $127M AUM
CF
Concorde Financial Dallas, Texas $127M AUM 24.97% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return

Bridger Management's Q2 2024 Portfolio in Review

As of Q2 2024, Bridger Management held 33 positions worth $194M, down 12% from $222M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bridger Management withdrew a net $34M in Q2 2024, closing 5 positions and reducing 4 holdings. Its most notable exit was Endeavor Group Holdings, Inc., an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bridger Management opened a new position in Bausch + Lomb worth $7.35M.

  • Bridger Management's largest Q2 2024 buy was Bausch + Lomb: 506,343 shares worth $7.35M.
  • Bridger Management added most to Melco Resorts & Entertainment in Q2 2024, an estimated $896K increase.
  • Bridger Management's biggest Q2 2024 reduction was Teva Pharmaceuticals, cutting an estimated $7.99M.
  • Bridger Management fully exited Endeavor Group Holdings, Inc. in Q2 2024, selling an estimated $11.4M.
  • Bridger Management's ten largest holdings make up 73% of its $194M portfolio in Q2 2024.
  • Bridger Management opened 2 new positions and closed 5 in Q2 2024.
  • Bridger Management's portfolio value fell 12% quarter-over-quarter to $194M.

Based on Bridger Management's 13F filing for Q2 2024, filed 14 Aug 2024.